Company’s 36-month beta value is 1.39.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NTRA is 112.88M, and currently, short sellers hold a 7.05% ratio of that floaft. The average trading volume of NTRA on April 04, 2024 was 1.52M shares.
NTRA) stock’s latest price update
The stock price of Natera Inc (NASDAQ: NTRA) has jumped by 0.76 compared to previous close of 91.91. Despite this, the company has seen a gain of 2.90% in its stock price over the last five trading days. Seeking Alpha reported 2024-03-22 that The global market size for personalized medicines is estimated to reach $1,233.23 billion by 2033, with North America experiencing significant growth in the oncology sector. Natera Inc., a diagnostic company, focuses on women’s health, oncology, and organ health, with major revenue drivers including non-invasive prenatal tests and personalized molecular residual disease tests. Natera reported a 43% year-on-year increase in revenue in Q4 2023, with a goal to achieve cash flow break even by Q3 2024 or sooner.
NTRA’s Market Performance
Natera Inc (NTRA) has experienced a 2.90% rise in stock performance for the past week, with a 2.66% rise in the past month, and a 49.56% rise in the past quarter. The volatility ratio for the week is 3.55%, and the volatility levels for the past 30 days are at 3.50% for NTRA. The simple moving average for the past 20 days is 2.25% for NTRA’s stock, with a 58.40% simple moving average for the past 200 days.
Analysts’ Opinion of NTRA
Many brokerage firms have already submitted their reports for NTRA stocks, with Raymond James repeating the rating for NTRA by listing it as a “Outperform.” The predicted price for NTRA in the upcoming period, according to Raymond James is $85 based on the research report published on February 20, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see NTRA reach a price target of $85, previously predicting the price at $75. The rating they have provided for NTRA stocks is “Buy” according to the report published on December 29th, 2023.
Guggenheim gave a rating of “Buy” to NTRA, setting the target price at $70 in the report published on December 14th of the previous year.
NTRA Trading at 17.33% from the 50-Day Moving Average
After a stumble in the market that brought NTRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.77% of loss for the given period.
Volatility was left at 3.50%, however, over the last 30 days, the volatility rate increased by 3.55%, as shares surge +5.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +38.89% upper at present.
During the last 5 trading sessions, NTRA rose by +2.90%, which changed the moving average for the period of 200-days by +82.59% in comparison to the 20-day moving average, which settled at $90.82. In addition, Natera Inc saw 47.84% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NTRA starting from Chapman Steven Leonard, who sale 2,662 shares at the price of $90.42 back on Mar 28 ’24. After this action, Chapman Steven Leonard now owns 234,526 shares of Natera Inc, valued at $240,687 using the latest closing price.
Sheena Jonathan, the CO-FOUNDER of Natera Inc, sale 1,000 shares at $90.13 during a trade that took place back on Mar 28 ’24, which means that Sheena Jonathan is holding 69,582 shares at $90,130 based on the most recent closing price.
Stock Fundamentals for NTRA
Current profitability levels for the company are sitting at:
- -0.41 for the present operating margin
- 0.46 for the gross margin
The net margin for Natera Inc stands at -0.4. The total capital return value is set at -0.39. Equity return is now at value -59.11, with -30.28 for asset returns.
Based on Natera Inc (NTRA), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at -0.66. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is -35.31.
Currently, EBITDA for the company is -404.95 million with net debt to EBITDA at 0.47. When we switch over and look at the enterprise to sales, we see a ratio of 10.01. The receivables turnover for the company is 3.89for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
In a nutshell, Natera Inc (NTRA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
